Correlation Between Day One and Solid Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Day One and Solid Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Solid Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Solid Biosciences LLC, you can compare the effects of market volatilities on Day One and Solid Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Solid Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Solid Biosciences.

Diversification Opportunities for Day One and Solid Biosciences

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Day and Solid is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Solid Biosciences LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Solid Biosciences LLC and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Solid Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Solid Biosciences LLC has no effect on the direction of Day One i.e., Day One and Solid Biosciences go up and down completely randomly.

Pair Corralation between Day One and Solid Biosciences

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Solid Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 1.51 times less risky than Solid Biosciences. The stock trades about -0.07 of its potential returns per unit of risk. The Solid Biosciences LLC is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  552.00  in Solid Biosciences LLC on September 1, 2024 and sell it today you would earn a total of  18.00  from holding Solid Biosciences LLC or generate 3.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Day One Biopharmaceuticals  vs.  Solid Biosciences LLC

 Performance 
       Timeline  
Day One Biopharmaceu 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Day One Biopharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Solid Biosciences LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Solid Biosciences LLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Day One and Solid Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Day One and Solid Biosciences

The main advantage of trading using opposite Day One and Solid Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Solid Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Solid Biosciences will offset losses from the drop in Solid Biosciences' long position.
The idea behind Day One Biopharmaceuticals and Solid Biosciences LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites